MSSVX
Price
$10.24
Change
-$0.12 (-1.16%)
Updated
Jul 10 closing price
Net Assets
104.67M
VSGIX
Price
$99.69
Change
-$0.93 (-0.92%)
Updated
Jul 10 closing price
Net Assets
47.01B
Interact to see
Advertisement

MSSVX vs VSGIX

MSSVX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
MSSVX vs. VSGIX commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSSVX is a Buy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 47B vs. MSSVX (105M). MSSVX pays higher dividends than VSGIX: MSSVX (1.39) vs VSGIX (0.42). MSSVX was incepted earlier than VSGIX: MSSVX (17 years) vs VSGIX (26 years). MSSVX (1.50) is less costly to investors than VSGIX (0.05). MSSVX is a more actively managed with annual turnover of: 290.00 vs. VSGIX (24.00). MSSVX has a lower initial minimum investment than VSGIX: MSSVX (2000) vs VSGIX (5000000). MSSVX annual gain was more profitable for investors over the last year : 30.86 vs. VSGIX (25.28). VSGIX return over 5 years is better than : 23.45 vs. MSSVX (-10.29).
MSSVXVSGIXMSSVX / VSGIX
Total Expense Ratio1.300.052,600%
Annual Report Gross Expense Ratio1.500.053,000%
Fund Existence17 years26 years-
Gain YTD21.18317.383122%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets105M47B0%
Annual Yield % from dividends1.390.42328%
Returns for 1 year30.8625.28122%
Returns for 3 years38.5152.4573%
Returns for 5 years-10.2923.45-44%
Returns for 10 years6.32180.514%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSVAX19.800.06
+0.30%
Loomis Sayles Small Cap Value Admin
JDVPX29.240.08
+0.27%
JHancock Disciplined Value R2
PIGCX32.600.07
+0.22%
Putnam International Equity C
ISIPX22.22N/A
N/A
Voya US Stock Index Port S2
TSCGX21.95-0.20
-0.90%
Thrivent Small Cap Growth S